Holger Liepmann has served as a director of Enzymotec since February 2015. Mr. Liepmann served in various positions with Abbott Laboratories from 1986 until his retirement in 2011. From 2006 to 2011, he served as executive vice president, Nutritional Products of Abbott Laboratories. In this capacity he was responsible for all aspects of Abbott Laboratories' global nutritional business, including R&D, manufacturing, supply chain and commercial operations, and reported to Abbott's CEO. Previously, he served as executive vice president, Pharmaceutical Products Group, senior vice president, Abbott International, the commercial operations for Abbott's international pharmaceutical business, and vice president Japan Operations. He enjoyed an international career with postings in Japan, Spain, Puerto Rico, Germany and the US. Prior to joining Abbott, Mr. Liepmann worked for Bayer AG in a variety of capacities between 1975 and 1986, both in the US and in Germany. Mr. Liepmann earned a bachelor's degree from Dartmouth College and a master's degree in business administration from Stanford University.